Project Grant S10OD038233

Award Date 5/15/25
Completion Date 5/14/26
Dollars Obligated $1.5M
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program, provides $460,500 to the University of New Hampshire to develop novel bioprinting methodologies for producing human stem cell-based organoids. The key objectives are to: Create a customized bioink formulation incorporating gelatin, collagen, crosslinking...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant of $274,829 awarded to Rosebud Biosciences Inc. on August 15, 2023 aims to enable the development of new therapies for rare diseases in children. The project objectives are to: (1) Automate the derivation of heart, liver, and brain organoids from human stem cells, and (2) Develop automated machine learning models to detect disease phenotypes in these organoids derived from patients with...
This Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) will provide $1,869,146 to the University of California, Los Angeles (UCLA) to purchase the CellXpress.AI Automated Cell Culture System. The new instrument will enable researchers at UCLA to scale cell culture production in support of high-throughput screening campaigns and the development of advanced cellular models like engineered cell lines, organoids, and...
This $500,000 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences, under the Biological Sciences federal grant program (CFDA 47.074), will support research to develop an end-to-end continuous manufacturing process for cell therapies using robotics and microfluidic technologies. The Georgia Tech Research Corporation will receive funding to create a more integrated workflow based on microfluidic device-enabled genetic engineering, cell expansion, and...
The Stanford University received a three-year $2.83 million Project Grant from the Department of Health and Human Services National Institutes of Health Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant will support development of novel methods to dramatically reduce the cost of stem cell maintenance and increase the scale of organoid production for organ biofabrication applications. Specifically, the university will engineer growth factor-free human...
The National Institutes of Health National Institute of General Medical Sciences awarded New Jersey Institute of Technology a $832,624 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to develop an automated microfluidics technology for minimally disruptive analysis of cells and fluids within living 3D cultures. The three-year project beginning July 1, 2022 aims to design a novel microfluidic plumbing architecture capable of performing thousands of XYZ...
This $1.5 million Project Grant from the National Science Foundation (NSF), under the Engineering federal grant program (CFDA 47.041), will fund research at the University of California Irvine from October 2022 through September 2026. The university will develop hydrogel-based bioengineering technologies to reproducibly generate distinct spatial organization and cellular diversity within cortical organoids, mimicking the development of different brain regions. Researchers will leverage expertise...
This $299,844 Project Grant awarded by the National Science Foundation (NSF) under the STEM Education program (CFDA 47.076) supports the development of a microfluidic cortical organoid-vasculature platform at North Carolina Agricultural and Technical State University (NC A&T). The project aims to establish a new framework for "organoid-vasculature intelligence" by integrating the organoid platform with microelectrode array recording/stimulation and machine learning models. The...
The federal Project Grant award R43OD037625, funded by the Department of Health and Human Services' National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351), supports the development of an innovative machine vision guided robotic system to automate microinjection procedures for Drosophila melanogaster (fruit fly) embryos. Objective Biotechnology, Inc., a biotechnology spin-out from the University of Minnesota, is pioneering this automated microinjection...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Dragonase LLC in Minneapolis, MN to develop a fully autonomous robotic wet lab for optimizing hematopoietic stem cell (HSC) culture media. The project, running from June 2025 to February 2026, aims to build a "machine biologist" system consisting of a robotic wet lab and machine learning computer vision models to rapidly and...

This federal Project Grant award, provided by the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351), supports the acquisition and integration of an automated robotic culture system for organoid generation, maintenance, and phenotyping at Emory University's Organoid Hub. The $1,521,607 grant, awarded on May 15, 2025, will enable the university to automate its organoid culture capabilities, enhancing standardization, scalability, and accessibility. This system will reduce hands-on time, minimize human error, and ensure consistent, reproducible results across various organoid types, including brain, gut, cardiac, and kidney organoids. By offering a fee-for-use service, the Organoid Hub will provide researchers access to this cutting-edge automated technology, facilitating groundbreaking research in human cellular biology and disease modeling.

Generated 6/17/25, 5:01 AM